Taro Pharmaceutical Industries Ltd (TARO)
42.26
+0.07
(+0.17%)
USD |
NYSE |
Apr 19, 16:00
42.23
-0.03
(-0.07%)
After-Hours: 18:05
Taro Pharmaceutical Industries Profit Margin (Quarterly): 12.86% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 12.86% |
| September 30, 2023 | 5.77% |
| June 30, 2023 | 6.31% |
| March 31, 2023 | 4.72% |
| December 31, 2022 | 5.22% |
| September 30, 2022 | -2.16% |
| June 30, 2022 | 8.99% |
| March 31, 2022 | 19.13% |
| December 31, 2021 | 18.93% |
| September 30, 2021 | 17.67% |
| June 30, 2021 | -12.76% |
| March 31, 2021 | -20.08% |
| December 31, 2020 | 23.49% |
| September 30, 2020 | 31.60% |
| June 30, 2020 | -369.7% |
| March 31, 2020 | 30.98% |
| December 31, 2019 | 45.83% |
| September 30, 2019 | 34.93% |
| June 30, 2019 | 41.03% |
| March 31, 2019 | 32.48% |
| December 31, 2018 | 53.01% |
| September 30, 2018 | 39.35% |
| June 30, 2018 | 43.51% |
| March 31, 2018 | 49.25% |
| December 31, 2017 | 11.56% |
| Date | Value |
|---|---|
| September 30, 2017 | 30.83% |
| June 30, 2017 | 33.78% |
| March 31, 2017 | 42.25% |
| December 31, 2016 | 63.44% |
| September 30, 2016 | 54.05% |
| June 30, 2016 | 47.01% |
| March 31, 2016 | 43.37% |
| December 31, 2015 | 73.16% |
| September 30, 2015 | 62.88% |
| June 30, 2015 | 48.14% |
| March 31, 2015 | 62.37% |
| December 31, 2014 | 59.94% |
| September 30, 2014 | 57.16% |
| June 30, 2014 | 35.40% |
| March 31, 2014 | 47.89% |
| December 31, 2013 | 54.13% |
| September 30, 2013 | 46.92% |
| June 30, 2013 | 38.38% |
| March 31, 2013 | 29.77% |
| December 31, 2012 | 47.81% |
| September 30, 2012 | 40.60% |
| June 30, 2012 | 39.53% |
| March 31, 2012 | 32.56% |
| December 31, 2011 | 42.13% |
| September 30, 2011 | 42.63% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-369.7%
Minimum
Jun 2020
45.83%
Maximum
Dec 2019
-5.12%
Average
12.86%
Median
Dec 2023
Profit Margin (Quarterly) Benchmarks
| InspireMD Inc | -306.9% |
| Ayala Pharmaceuticals Inc | -- |
| BiomX Inc | -- |
| Alpha Tau Medical Ltd | -- |
| Pluri Inc | -4.67K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 2.63% |
| Return on Assets | 2.14% |
| Return on Invested Capital | 2.61% |
| Gross Profit Margin (Quarterly) | 50.83% |
| Operating Margin (Quarterly) | 10.11% |
| Return on Net Operating Assets | 6.55% |